TY - JOUR
T1 - Integrative Medicine Across the Pediatric Cancer Care Trajectory
T2 - A Narrative Review
AU - Ben-Arye, Eran
AU - Samuels, Noah
AU - Seifert, Georg
AU - Gressel, Orit
AU - Peleg, Raviv
AU - Jong, Miek
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/6
Y1 - 2024/6
N2 - Purpose of the review: Children and adolescents with cancer, along with their parents and other informal caregivers, often report using complementary and alternative medicine (CAM) during active oncology and hemato-oncology treatment. Some adopt an “alternative” approach to conventional medical care, which often entails the use of these practices without the knowledge of the treating pediatrician. In contrast, many others search for consultation provided by a pediatric integrative oncology (IO) practitioner working with the conventional medical team. IO seeks to provide evidence-based complementary medicine therapies, many of which have been shown to augment conventional supportive and palliative care, while ensuring the patient’s safety. The present narrative review examines the current state of and future direction for the IO setting of care. Recent findings: A large body of published clinical research supports the effectiveness of leading Pediatric IO modalities, while addressing potential safety-related concerns. Summary: Despite the growing amount of clinical research supporting the beneficial effects and implementation of Pediatric IO models of care, there is still a need for further studies in order to establish clinical guidelines in the treatment of children and adolescents with cancer. Such IO-directed guidelines will need to address both the effectiveness and the safety of the CAM modalities being used in pediatric oncology and hemato-oncology settings, promoting a better understanding among pediatric healthcare professionals and helping them understand the indications for referral to the IO treatment service.
AB - Purpose of the review: Children and adolescents with cancer, along with their parents and other informal caregivers, often report using complementary and alternative medicine (CAM) during active oncology and hemato-oncology treatment. Some adopt an “alternative” approach to conventional medical care, which often entails the use of these practices without the knowledge of the treating pediatrician. In contrast, many others search for consultation provided by a pediatric integrative oncology (IO) practitioner working with the conventional medical team. IO seeks to provide evidence-based complementary medicine therapies, many of which have been shown to augment conventional supportive and palliative care, while ensuring the patient’s safety. The present narrative review examines the current state of and future direction for the IO setting of care. Recent findings: A large body of published clinical research supports the effectiveness of leading Pediatric IO modalities, while addressing potential safety-related concerns. Summary: Despite the growing amount of clinical research supporting the beneficial effects and implementation of Pediatric IO models of care, there is still a need for further studies in order to establish clinical guidelines in the treatment of children and adolescents with cancer. Such IO-directed guidelines will need to address both the effectiveness and the safety of the CAM modalities being used in pediatric oncology and hemato-oncology settings, promoting a better understanding among pediatric healthcare professionals and helping them understand the indications for referral to the IO treatment service.
KW - Complementary alternative medicine
KW - Integrative medicine
KW - Integrative oncology
KW - Pediatric hemato-oncology
KW - Pediatric oncology
UR - http://www.scopus.com/inward/record.url?scp=85192803400&partnerID=8YFLogxK
U2 - 10.1007/s11912-024-01538-1
DO - 10.1007/s11912-024-01538-1
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 38733465
AN - SCOPUS:85192803400
SN - 1523-3790
VL - 26
SP - 714
EP - 734
JO - Current Oncology Reports
JF - Current Oncology Reports
IS - 6
ER -